ClinicalTrials.gov
ClinicalTrials.gov Menu

Non Invasive Diagnostic of Endometrial Receptivity

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01588223
Recruitment Status : Completed
First Posted : April 30, 2012
Last Update Posted : March 27, 2014
Sponsor:
Information provided by (Responsible Party):
Carlos Simon, Instituto Valenciano de Infertilidad, IVI VALENCIA

Brief Summary:
The purpose of this study is to determine a lipidomic profile on the endometrial fluid, that can predict endometrial receptivity.

Condition or disease Intervention/treatment Phase
Endometrial Receptivity Failure Other: Lipid identification Not Applicable

Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 40 participants
Allocation: Non-Randomized
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Diagnostic
Official Title: A Non Invasive Diagnostic of Endometrial Receptivity Based on Lipidomic Profile on Endometrial Fluid.
Study Start Date : January 2011
Actual Primary Completion Date : May 2012
Actual Study Completion Date : May 2012

Arm Intervention/treatment
Experimental: Lipids Other: Lipid identification
The lipids are identified using Mass Spectrometry




Primary Outcome Measures :
  1. Levels of lipids in the endometrial fluid as a diagnostic factor. [ Time Frame: 1 year ]


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years to 35 Years   (Adult)
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Oocyte donors undergoing controlled ovarian stimulation
  • Regular menstrual cycles
  • no abnormal karyotype
  • generally healthy
  • BMI 19-29 Kg/m2 (both inclusive)
  • 18 to 35 years old.

Exclusion criteria:

-patients diagnosed with endometriosis and/or endometritis.


Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01588223


Locations
Spain
IVI Valencia
Valencia, Spain, 46015
Sponsors and Collaborators
Igenomix

Responsible Party: Carlos Simon, Prof. Carlos Simon, MD PhD, Instituto Valenciano de Infertilidad, IVI VALENCIA
ClinicalTrials.gov Identifier: NCT01588223     History of Changes
Other Study ID Numbers: 1002-C-069-OB
First Posted: April 30, 2012    Key Record Dates
Last Update Posted: March 27, 2014
Last Verified: March 2014